May 10, 2019 / 03:30AM GMT
Presentation
May 10, 2019 / 03:30AM GMT
=====================
Corporate Participants
=====================
* Akira Kurokawa
Santen Pharmaceutical Co., Ltd. - Chairman & CEO
* Kazuo Koshiji
Santen Pharmaceutical Co., Ltd. - Senior Corp. Officer of Corporate Administration, CFO and Head of Finance & Administration Division
* Naveed Shams
Santen Pharmaceutical Co., Ltd. - Senior Corporate Officer, Chief Scientific Officer and Head of Global Research & Development
* Shigeo Taniuchi
Santen Pharmaceutical Co., Ltd. - President, COO, Head of North America Business & Representative Director
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc, Research Division - MD and Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research
Santen Pharmaceutical Co Ltd
(OTCPK:SNPHY)
$
10.63
0.01 (0.09%)
Market Cap: 3.71 Bil
Enterprise Value: 3.70 Bil
PE Ratio: 21.47
PB Ratio: 1.99
GF Score: 76/100 Full Year 2019 Santen Pharmaceutical Co Ltd Earnings Presentation Transcript
May 10, 2019 / 03:30AM GMT
Release Date Price:
$15.31
(-1.86%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers